FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387675887> ?p ?o ?g. }

• W4387675887 abstract "Cancer stem cells (CSCs) are found in many solid tumors, which play decisive roles in the occurrence, recurrence and metastasis of tumors. However, drugs are difficult to kill CSCs due to their limited number and location in oxygen-deprived tissue far from the blood vessels. Meanwhile, the survival and stemness maintenance of CSCs strongly depend on the tumor microenvironment (TME). Herein, we developed a CD44 antibody modified iridium nanosheet with enzyme-like activity (defined as Ir Nts-Ab) that effectively eradicates CSCs for cancer therapy. We observe that Ir Nts-Ab can enrich tumor tissues to remove excessive reactive oxygen species and produce oxygen, thus alleviating hypoxia and the inflammatory TME to reduce the proportion of CSCs and inhibit metastasis. In addition, Ir Nts-Ab targets CSCs and normal cancer cells with near infrared II-region photothermal therapy (NIR-II PTT), and is easily taken up by CSCs due to recognition of the CD44 proteins. Moreover, photoacoustic imaging helps monitor drug accumulation and hypoxic TME improvement in tumor tissue. Importantly, Ir Nts-Ab has good biological safety, making it suitable for biomedical applications. This iridium nanozyme based on TME regulation as well as NIR-II PTT will be a promising strategy for the treatment of cancer. Cancer stem cells (CSCs) are key factors that make tumors difficult to eradicate, and strongly depend on the hypoxic tumor microenvironment (TME), which plays a crucial role in the occurrence and metastasis of tumors. Herein, an antibody modified iridium nanosheet (definition as Ir Nts-Ab) was developed for targeted eradication of CSCs by photoacoustic imaging guided photothermal therapy (PTT) and TME regulation. Ir Nts-Ab with catalase-like activity could inhibit HIF-1α by producing oxygen, thus effectively reducing the proportion of CSCs and inhibiting tumor metastasis. Additionally, Ir Nts-Ab achieved the eradication of CSCs by PTT, and eliminated reactive oxygen species to decrease the inflammatory response, resulting in reduced tumor metastasis, which was promising for the cure of solid tumors in the clinics." @default.
• W4387675887 created "2023-10-17" @default.
• W4387675887 creator A5019027866 @default.
• W4387675887 creator A5019204335 @default.
• W4387675887 creator A5027130934 @default.
• W4387675887 creator A5027964885 @default.
• W4387675887 creator A5030911087 @default.
• W4387675887 creator A5045573976 @default.
• W4387675887 creator A5047098447 @default.
• W4387675887 creator A5058704811 @default.
• W4387675887 creator A5063155262 @default.
• W4387675887 creator A5077209124 @default.
• W4387675887 date "2023-10-01" @default.
• W4387675887 modified "2023-10-17" @default.
• W4387675887 title "Iridium Nanozyme-Mediated Photoacoustic Imaging-Guided NIR-II Photothermal Therapy and Tumor Microenvironment Regulation for Targeted Eradication of Cancer Stem Cells" @default.
• W4387675887 cites W1968044382 @default.
• W4387675887 cites W1999251458 @default.
• W4387675887 cites W2014167355 @default.
• W4387675887 cites W2079479316 @default.
• W4387675887 cites W2086667809 @default.
• W4387675887 cites W2093921289 @default.
• W4387675887 cites W2094908805 @default.
• W4387675887 cites W2116554142 @default.
• W4387675887 cites W2149124299 @default.
• W4387675887 cites W2256492013 @default.
• W4387675887 cites W2323751645 @default.
• W4387675887 cites W2324564321 @default.
• W4387675887 cites W2385884905 @default.
• W4387675887 cites W2550154271 @default.
• W4387675887 cites W2562595199 @default.
• W4387675887 cites W2563556731 @default.
• W4387675887 cites W2582081818 @default.
• W4387675887 cites W2586840087 @default.
• W4387675887 cites W2593074826 @default.
• W4387675887 cites W2761360410 @default.
• W4387675887 cites W2767392060 @default.
• W4387675887 cites W2808583997 @default.
• W4387675887 cites W2887705042 @default.
• W4387675887 cites W2902944417 @default.
• W4387675887 cites W2913475012 @default.
• W4387675887 cites W2953057790 @default.
• W4387675887 cites W2955641089 @default.
• W4387675887 cites W2977110700 @default.
• W4387675887 cites W2982182315 @default.
• W4387675887 cites W2990125990 @default.
• W4387675887 cites W2991163352 @default.
• W4387675887 cites W2997535973 @default.
• W4387675887 cites W2999304663 @default.
• W4387675887 cites W3012307045 @default.
• W4387675887 cites W3015833106 @default.
• W4387675887 cites W3017681580 @default.
• W4387675887 cites W3031239886 @default.
• W4387675887 cites W3085111925 @default.
• W4387675887 cites W3104081378 @default.
• W4387675887 cites W3110635005 @default.
• W4387675887 cites W3127481405 @default.
• W4387675887 cites W3128646645 @default.
• W4387675887 cites W3172039897 @default.
• W4387675887 cites W3184144635 @default.
• W4387675887 cites W3208247254 @default.
• W4387675887 cites W4200233375 @default.
• W4387675887 cites W4206347613 @default.
• W4387675887 cites W4221110400 @default.
• W4387675887 cites W4223612852 @default.
• W4387675887 cites W4237878273 @default.
• W4387675887 cites W4307907150 @default.
• W4387675887 cites W4309094761 @default.
• W4387675887 cites W4311579503 @default.
• W4387675887 cites W4318014964 @default.
• W4387675887 doi "https://doi.org/10.1016/j.actbio.2023.10.018" @default.
• W4387675887 hasPublicationYear "2023" @default.
• W4387675887 type Work @default.
• W4387675887 citedByCount "0" @default.
• W4387675887 crossrefType "journal-article" @default.
• W4387675887 hasAuthorship W4387675887A5019027866 @default.
• W4387675887 hasAuthorship W4387675887A5019204335 @default.
• W4387675887 hasAuthorship W4387675887A5027130934 @default.
• W4387675887 hasAuthorship W4387675887A5027964885 @default.
• W4387675887 hasAuthorship W4387675887A5030911087 @default.
• W4387675887 hasAuthorship W4387675887A5045573976 @default.
• W4387675887 hasAuthorship W4387675887A5047098447 @default.
• W4387675887 hasAuthorship W4387675887A5058704811 @default.
• W4387675887 hasAuthorship W4387675887A5063155262 @default.
• W4387675887 hasAuthorship W4387675887A5077209124 @default.
• W4387675887 hasBestOaLocation W43876758871 @default.
• W4387675887 hasConcept C121608353 @default.
• W4387675887 hasConcept C126322002 @default.
• W4387675887 hasConcept C1491633281 @default.
• W4387675887 hasConcept C171250308 @default.
• W4387675887 hasConcept C182606246 @default.
• W4387675887 hasConcept C185592680 @default.
• W4387675887 hasConcept C192562407 @default.
• W4387675887 hasConcept C2776107976 @default.
• W4387675887 hasConcept C2779013556 @default.
• W4387675887 hasConcept C2780932548 @default.
• W4387675887 hasConcept C502942594 @default.
• W4387675887 hasConcept C55427017 @default.
• W4387675887 hasConcept C55493867 @default.
• W4387675887 hasConcept C71924100 @default.
• W4387675887 hasConcept C96232424 @default.

• next